VEGFA and disease of the tendon: Treatment with an HIF inhibitor, Asperosaponin VI (ASA VI), promoted tendon repair via the upregulation of tenogenesis-associated markers such as SCX, TNC, collagen 1, and Mohawk X(MKX), and the downregulation of tendinopathy markers MMP, VEGF-A, and KDR.